What is the recommended dosage of amitriptyline (tricyclic antidepressant) or propranolol (beta blocker) for headache management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing for Amitriptyline and Propranolol in Headache Prevention

For migraine prevention, start amitriptyline at 30-150 mg daily or propranolol at 80-240 mg daily, as both are first-line agents with good evidence for efficacy. 1

First-Line Agent Selection

Both amitriptyline and propranolol are designated as first-line preventive agents for migraine by the AAFP/ACP-ASIM guidelines. 1 The choice between them depends on your patient's specific headache pattern and comorbidities:

Amitriptyline Dosing

  • Standard dosing range: 30-150 mg daily 1
  • Practical starting approach: Begin with 10-25 mg at bedtime 2
  • Increase gradually every 1-2 weeks as tolerated 1
  • Most patients in real-world practice respond to lower doses (10-25 mg daily) than used in clinical trials 3
  • Amitriptyline is superior to propranolol when patients have mixed migraine and tension-type headache 1
  • Particularly effective for chronic daily headache (≥17 days/month), showing 46% of patients achieving ≥50% improvement at 16 weeks 4

Propranolol Dosing

  • Standard dosing range: 80-240 mg daily 1, 5
  • FDA-approved starting dose: 80 mg once daily (extended-release formulation) 5
  • Increase to 120 mg once daily or higher until adequate control is achieved 5
  • Usual maintenance dosage: 120-160 mg once daily 5
  • Maximum studied dose: 640 mg daily, though most patients respond to lower doses 5
  • Propranolol is superior to amitriptyline for patients with migraine alone (without tension-type features) 1

Comparative Efficacy Evidence

A recent 2024 comparative study found amitriptyline more effective than propranolol at reducing migraine frequency, duration, and severity over 3 months of treatment. 6 However, the AAFP/ACP-ASIM guidelines note that one comparative trial suggested propranolol superiority in pure migraine, while amitriptyline was better for mixed headache types. 1

Titration Strategy

Start low and titrate slowly over weeks to months: 1

  • Clinical benefits may not become apparent for 2-3 months 1, 7
  • Increase dose gradually until benefits are achieved without adverse effects 1
  • An adequate trial requires reaching therapeutic dosing for at least 2-3 months before declaring treatment failure 1, 7

Common Pitfalls to Avoid

Abandoning therapy too early: Many clinicians discontinue preventive medications before the 2-3 month window needed to assess full efficacy. 1, 7

Inadequate dosing of amitriptyline: While real-world data shows efficacy at 10-25 mg daily 3, guideline-recommended dosing is 30-150 mg daily for optimal prevention. 1 Consider that lower doses may work for some patients, but don't assume failure without reaching at least 30 mg daily.

Not accounting for headache type: Using propranolol for mixed migraine/tension-type headache when amitriptyline would be more appropriate. 1

Side Effect Profile

Amitriptyline: Weight gain, drowsiness, anticholinergic symptoms (dry mouth, constipation). 1 In real-world practice, daytime fatigue occurs in approximately 11% of patients, but low-dose therapy (10-25 mg) is generally well-tolerated with 85% medication persistence. 3

Propranolol: Fatigue, depression, nausea, dizziness, insomnia—generally fairly well tolerated. 1

When to Discontinue or Taper

After achieving a period of stability (typically several months of good headache control), consider tapering or discontinuing the medication. 1 For propranolol specifically, withdraw gradually over several weeks depending on patient age, comorbidity, and dose. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Preventative Treatments for Occipital Headaches

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Verapamil Dosing for Migraine Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.